Sentiment-Signal
10,2
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (12.03.2026)
HOCH Abgang Schlüsselpersonen (12.03.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 12.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm |
| 30.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | erial Agreement The information set forth under Item 5.02 regarding the amendment and restatement of the Executive Chang |
| 07.07.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm |
| 27.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm |
| 06.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certa |
| 15.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointme |
Stammdaten
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Unternehmen & Branche
| Name | iRhythm Holdings, Inc. |
|---|---|
| Ticker | IRTC |
| CIK | 0001388658 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 4,13 Mrd. USD |
| Beta | 1,18 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 747,138,000 | -44,551,000 | -1.39 | 1,020,042,000 | 152,746,000 |
| 2025-09-30 | 10-Q | 192,884,000 | -5,212,000 | -0.16 | 995,214,000 | 121,893,000 |
| 2025-06-30 | 10-Q | 186,687,000 | -14,218,000 | -0.44 | 964,030,000 | 103,660,000 |
| 2025-03-31 | 10-Q | 158,677,000 | -30,700,000 | -0.97 | 926,098,000 | 86,665,000 |
| 2024-12-31 | 10-K | 591,839,000 | -113,289,000 | -3.63 | 931,449,000 | 90,908,000 |
| 2024-09-30 | 10-Q | 147,538,000 | -46,182,000 | -1.48 | 909,688,000 | 71,766,000 |
| 2024-06-30 | 10-Q | 148,047,000 | -20,107,000 | -0.65 | 919,185,000 | 99,189,000 |
| 2024-03-31 | 10-Q | 131,929,000 | -45,667,000 | -1.47 | 909,755,000 | 90,290,000 |
| 2023-12-31 | 10-K | 492,681,000 | -123,406,000 | -4.04 | 433,144,000 | 210,097,000 |
| 2023-09-30 | 10-Q | 124,604,000 | -27,116,000 | -0.89 | 439,769,000 | 219,795,000 |
| 2023-06-30 | 10-Q | 124,130,000 | -18,482,000 | -0.61 | 429,488,000 | 223,879,000 |
| 2023-03-31 | 10-Q | 111,436,000 | -39,109,000 | -1.29 | 421,701,000 | 221,834,000 |
| 2022-12-31 | 10-K | 410,921,000 | -116,155,000 | -3.88 | 448,222,000 | 239,812,000 |
| 2022-09-30 | 10-Q | 103,875,000 | -21,451,000 | -0.71 | 440,390,000 | 239,224,000 |
| 2022-06-30 | 10-Q | 102,051,000 | -23,897,000 | -0.80 | 435,686,000 | 244,642,000 |
| 2022-03-31 | 10-Q | 92,378,000 | -50,609,000 | -1.71 | 428,717,000 | 244,842,000 |
| 2021-12-31 | 10-K | 322,825,000 | -101,361,000 | -3.46 | 462,967,000 | 279,515,000 |
| 2021-09-30 | 10-Q | 85,432,000 | -23,731,000 | -0.81 | 480,250,000 | 295,840,000 |
| 2021-06-30 | 10-Q | 81,278,000 | -17,360,000 | -0.59 | 485,224,000 | 306,442,000 |
| 2021-03-31 | 10-Q | 74,311,000 | -27,779,000 | -0.95 | 478,487,000 | 309,572,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | Smith Mervin | Officer, EVP Strategic Business Ops | Open Market Sale | -2,585 | 114.30 | -295,465.50 | -68,4% | |
| 2026-03-02 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -5,423 | 128.44 | -696,552.35 | -161,2% | |
| 2026-03-02 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -4,347 | 128.44 | -558,332.59 | -129,2% | |
| 2026-03-02 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -4,043 | 128.44 | -519,288.98 | -120,2% | |
| 2026-03-02 | Murphy Patrick Michael | Officer, CBO and CLO | Open Market Sale | -2,028 | 128.44 | -260,473.68 | -60,3% | |
| 2026-03-02 | Murphy Patrick Michael | Officer, CBO and CLO | Open Market Sale | -1,190 | 128.44 | -152,848.96 | -35,4% | |
| 2026-03-02 | Murphy Patrick Michael | Officer, CBO and CLO | Open Market Sale | -1,139 | 128.45 | -146,301.25 | -33,9% | |
| 2026-03-02 | Smith Mervin | Officer, EVP Strategic Business Ops | Open Market Sale | -752 | 128.44 | -96,585.60 | -22,4% | |
| 2026-03-02 | Smith Mervin | Officer, EVP Strategic Business Ops | Open Market Sale | -600 | 128.44 | -77,066.82 | -17,8% | |
| 2026-03-02 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -1,261 | 128.45 | -161,978.60 | -37,5% | |
| 2026-03-02 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -815 | 128.44 | -104,679.50 | -24,2% | |
| 2026-03-02 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -755 | 128.44 | -96,971.22 | -22,4% | |
| 2026-03-02 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -564 | 128.45 | -72,447.10 | -16,8% | |
| 2026-03-02 | Rosenbaum Marc Wade | Officer, Chief Accounting Officer | Open Market Sale | -417 | 128.45 | -53,564.48 | -12,4% | |
| 2026-03-02 | Rosenbaum Marc Wade | Officer, Chief Accounting Officer | Open Market Sale | -399 | 128.45 | -51,250.35 | -11,9% | |
| 2026-03-02 | Patterson Chad | Officer, CHIEF COMM & PRODUCT OFFICER | Open Market Sale | -3,030 | 128.44 | -389,188.05 | -90,1% | |
| 2026-03-02 | Patterson Chad | Officer, CHIEF COMM & PRODUCT OFFICER | Open Market Sale | -1,414 | 128.44 | -181,616.14 | -42,0% | |
| 2026-03-02 | Shrishrimal Sumi | Officer, EVP, Chief Risk Officer | Open Market Sale | -978 | 128.44 | -125,615.88 | -29,1% | |
| 2026-03-02 | Shrishrimal Sumi | Officer, EVP, Chief Risk Officer | Open Market Sale | -946 | 128.44 | -121,502.54 | -28,1% | |
| 2026-03-02 | Shrishrimal Sumi | Officer, EVP, Chief Risk Officer | Open Market Sale | -906 | 128.44 | -116,365.46 | -26,9% | |
| 2026-03-02 | Turakhia Minang | Officer, CHIEF MED/SCI OFCR EVP ADVTECH | Open Market Sale | -1,487 | 128.45 | -190,997.72 | -44,2% | |
| 2026-03-02 | Turakhia Minang | Officer, CHIEF MED/SCI OFCR EVP ADVTECH | Open Market Sale | -1,230 | 128.45 | -157,997.19 | -36,6% | |
| 2026-03-02 | Turakhia Minang | Officer, CHIEF MED/SCI OFCR EVP ADVTECH | Open Market Sale | -1,310 | 128.45 | -168,264.26 | -38,9% | |
| 2026-02-25 | Turakhia Minang | Officer, CHIEF MED/SCI OFCR EVP ADVTECH | Open Market Sale | -7,804 | 135.42 | -1,056,809.10 | -244,6% | |
| 2026-02-25 | Smith Mervin | Officer, EVP Strategic Business Ops | Open Market Sale | -4,041 | 135.42 | -547,227.77 | -126,7% | |
| 2026-02-25 | Murphy Patrick Michael | Officer, CBO and CLO | Open Market Sale | -7,805 | 135.42 | -1,056,944.51 | -244,6% | |
| 2026-02-25 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -25,540 | 135.42 | -3,458,598.71 | -800,5% | |
| 2026-02-25 | Patterson Chad | Officer, CHIEF COMM & PRODUCT OFFICER | Open Market Sale | -8,967 | 135.42 | -1,214,301.28 | -281,1% | |
| 2026-02-25 | Rosenbaum Marc Wade | Officer, Chief Accounting Officer | Open Market Sale | -4,797 | 135.42 | -649,604.46 | -150,4% | |
| 2026-02-25 | Shrishrimal Sumi | Officer, EVP, Chief Risk Officer | Open Market Sale | -6,217 | 135.42 | -841,899.30 | -194,9% | |
| 2026-02-25 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -5,188 | 135.42 | -702,553.25 | -162,6% | |
| 2026-02-24 | Smith Mervin | Officer, EVP Strategic Business Ops | Open Market Sale | -732 | 140.91 | -103,146.12 | -23,9% | |
| 2026-02-24 | Rosenbaum Marc Wade | Officer, Chief Accounting Officer | Open Market Sale | -280 | 140.91 | -39,454.80 | -9,1% | |
| 2026-02-23 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -1,378 | 143.40 | -197,605.20 | -45,7% | |
| 2026-02-23 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -572 | 146.95 | -84,055.97 | -19,5% | |
| 2026-02-23 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -1,637 | 147.62 | -241,647.39 | -55,9% | |
| 2026-02-23 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -1,725 | 145.32 | -250,671.83 | -58,0% | |
| 2025-12-02 | Murphy Patrick Michael | Officer, CBO and CLO | Open Market Sale | -2,478 | 184.83 | -458,008.74 | -106,0% | |
| 2025-12-02 | Patterson Chad | Officer, CHIEF COMM & PRODUCT OFFICER | Open Market Sale | -280 | 184.83 | -51,752.40 | -12,0% | |
| 2025-11-10 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -1,479 | 172.32 | -254,858.91 | -59,0% | |
| 2025-11-10 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -1,300 | 174.94 | -227,427.46 | -52,6% | |
| 2025-11-10 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -637 | 175.96 | -112,084.16 | -25,9% | |
| 2025-11-10 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -222 | 172.83 | -38,367.15 | -8,9% | |
| 2025-11-10 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -89 | 177.85 | -15,828.65 | -3,7% | |
| 2025-11-10 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -1,585 | 174.38 | -276,395.31 | -64,0% | |
| 2025-11-03 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -14,059 | 182.94 | -2,571,907.07 | -595,3% | |
| 2025-10-31 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -8,000 | 207.44 | -1,659,520.00 | -384,1% | |
| 2025-09-03 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -5,000 | 175.00 | -875,000.00 | -202,5% | |
| 2025-09-02 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -737 | 167.28 | -123,285.36 | -28,5% | |
| 2025-08-22 | Shrishrimal Sumi | Officer, EVP, Chief Risk Officer | Open Market Sale | -653 | 167.12 | -109,129.36 | -25,3% | |
| 2025-08-11 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -2,129 | 158.68 | -337,828.02 | -78,2% | |
| 2025-08-11 | Rosenbaum Marc Wade | Officer, Chief Accounting Officer | Open Market Sale | -226 | 158.93 | -35,918.18 | -8,3% | |
| 2025-08-11 | TALWALKAR ABHIJIT Y | Director | Open Market Sale | -3,183 | 157.57 | -501,552.63 | -116,1% | |
| 2025-08-06 | Patterson Chad | Officer, Chief Commercial Officer | Open Market Sale | -2,555 | 158.97 | -406,168.35 | -94,0% | |
| 2025-08-05 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -9,775 | 160.06 | -1,564,576.73 | -362,1% | |
| 2025-08-05 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -8,726 | 158.85 | -1,386,157.39 | -320,8% | |
| 2025-08-05 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -4,905 | 160.73 | -788,360.54 | -182,5% | |
| 2025-08-05 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -3,174 | 163.93 | -520,300.81 | -120,4% | |
| 2025-08-05 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -1,600 | 161.92 | -259,076.00 | -60,0% | |
| 2025-08-05 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -306 | 165.00 | -50,490.00 | -11,7% | |
| 2025-08-05 | Blackford Quentin S. | Director, Officer, President and CEO | Open Market Sale | -1,514 | 163.30 | -247,229.99 | -57,2% | |
| 2025-08-04 | Patterson Chad | Officer, Chief Commercial Officer | Open Market Sale | -2,707 | 164.36 | -444,921.71 | -103,0% | |
| 2025-08-04 | Smith Mervin | Officer, EVP Strategic Business Ops | Open Market Sale | -616 | 164.36 | -101,245.58 | -23,4% | |
| 2025-07-02 | Turakhia Minang | Officer, EVP, CMO & CSO | Open Market Sale | -1,420 | 145.41 | -206,482.20 | -47,8% | |
| 2025-06-23 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -3,000 | 150.00 | -450,000.00 | -104,2% | |
| 2025-06-23 | Patterson Chad | Officer, Chief Commercial Officer | Open Market Sale | -936 | 150.00 | -140,400.00 | -32,5% | |
| 2025-06-10 | Patterson Chad | Officer, Chief Commercial Officer | Open Market Sale | -363 | 150.00 | -54,450.00 | -12,6% | |
| 2025-06-02 | Rosenbaum Marc W. | Officer, Chief Accounting Officer | Open Market Sale | -696 | 140.21 | -97,586.16 | -22,6% | |
| 2025-06-02 | Shrishrimal Sumi | Officer, EVP, Chief Risk Officer | Open Market Sale | -1,608 | 140.21 | -225,457.68 | -52,2% | |
| 2025-05-02 | Wilson Daniel G. | Officer, Chief Financial Officer | Open Market Sale | -2,000 | 125.00 | -250,000.00 | -57,9% | |
| 2025-05-02 | Patterson Chad | Officer, Chief Commercial Officer | Open Market Sale | -1,300 | 125.00 | -162,500.00 | -37,6% | |
| 2025-05-02 | Patterson Chad | Officer, Chief Commercial Officer | Open Market Sale | -7,210 | 119.75 | -863,397.50 | -199,8% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.